Fezza F et al. |
Endocannabinoids, related compounds and their metabolic routes. |
2014 |
Molecules |
pmid:25347455
|
Muccioli GG et al. |
The endocannabinoid system links gut microbiota to adipogenesis. |
2010 |
Mol. Syst. Biol. |
pmid:20664638
|
Neumeister A et al. |
Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. |
2013 |
Mol. Psychiatry |
pmid:23670490
|
Rockwell CE et al. |
Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2. |
2006 |
Mol. Pharmacol. |
pmid:16611855
|
Raman P et al. |
15-Deoxy-delta12,14-prostaglandin J2-glycerol ester, a putative metabolite of 2-arachidonyl glycerol, activates peroxisome proliferator activated receptor gamma. |
2011 |
Mol. Pharmacol. |
pmid:21511917
|
Yates ML and Barker EL |
Inactivation and biotransformation of the endogenous cannabinoids anandamide and 2-arachidonoylglycerol. |
2009 |
Mol. Pharmacol. |
pmid:19389920
|
Jung KM et al. |
A key role for diacylglycerol lipase-alpha in metabotropic glutamate receptor-dependent endocannabinoid mobilization. |
2007 |
Mol. Pharmacol. |
pmid:17584991
|
Jäntti MH et al. |
Autocrine endocannabinoid signaling through CB1 receptors potentiates OX1 orexin receptor signaling. |
2013 |
Mol. Pharmacol. |
pmid:23233488
|
Dinh TP et al. |
RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol. |
2004 |
Mol. Pharmacol. |
pmid:15272052
|
He F et al. |
Involvement of the 90-kDa heat shock protein (Hsp-90) in CB2 cannabinoid receptor-mediated cell migration: a new role of Hsp-90 in migration signaling of a G protein-coupled receptor. |
2007 |
Mol. Pharmacol. |
pmid:17698952
|
Jain T et al. |
Diacylglycerol lipaseα (DAGLα) and DAGLβ cooperatively regulate the production of 2-arachidonoyl glycerol in autaptic hippocampal neurons. |
2013 |
Mol. Pharmacol. |
pmid:23748223
|
Lichtman AH et al. |
Endocannabinoid overload. |
2010 |
Mol. Pharmacol. |
pmid:20952498
|
Gonsiorek W et al. |
Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. |
2000 |
Mol. Pharmacol. |
pmid:10779390
|
Carrier EJ et al. |
Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. |
2004 |
Mol. Pharmacol. |
pmid:15044630
|
Laitinen T et al. |
Mutation of Cys242 of human monoacylglycerol lipase disrupts balanced hydrolysis of 1- and 2-monoacylglycerols and selectively impairs inhibitor potency. |
2014 |
Mol. Pharmacol. |
pmid:24368842
|
Jung KM et al. |
Stimulation of endocannabinoid formation in brain slice cultures through activation of group I metabotropic glutamate receptors. |
2005 |
Mol. Pharmacol. |
pmid:16051747
|
Straiker A et al. |
Monoacylglycerol lipase limits the duration of endocannabinoid-mediated depolarization-induced suppression of excitation in autaptic hippocampal neurons. |
2009 |
Mol. Pharmacol. |
pmid:19767452
|
Ouyang Y et al. |
Suppression of interleukin-2 by the putative endogenous cannabinoid 2-arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells. |
1998 |
Mol. Pharmacol. |
pmid:9547358
|
Guo J and Ikeda SR |
Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons. |
2004 |
Mol. Pharmacol. |
pmid:14978245
|
Delgado-Peraza F et al. |
Mechanisms of Biased β-Arrestin-Mediated Signaling Downstream from the Cannabinoid 1 Receptor. |
2016 |
Mol. Pharmacol. |
pmid:27009233
|